Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: the VELOCITY study
17 May 2025 (08:00 - 12:45)
Organised by: 
About the speaker
Duke Clinical Research Institute, Durham (United States of America)
6 More presentations in this session
Doctor A. Porcari (London, GB)
Professor I. Olivotto (Florence, IT)
Doctor J. Nunez Villota (Valencia, ES)
Doctor A. Muslin (Watertown, US)
Access the full session
The Event
Heart Failure 2025
17 May - 20 May 2025
You may be interested in
Congress Presentation
Congress Presentation
